Antimicrobial therapy in German Shepherd dog pyoderma (GSP). An open clinical study

Area of Science:

• Veterinary Dermatology
• Antimicrobial Therapy
• Canine Bacterial Infections

Background:

• German Shepherd Dog Pyoderma (GSP) is a common bacterial skin infection in the breed.
• Effective antimicrobial treatment is crucial for managing GSP and preventing complications.

Purpose of the Study:

• To evaluate the efficacy of enrofloxacin as an antimicrobial treatment for German Shepherd Dog Pyoderma (GSP).

Main Methods:

• A clinical study involving 27 German Shepherd dogs (25 pure-bred, 2 cross-bred) diagnosed with GSP.
• Oral administration of enrofloxacin at a dose of 5 mg/kg once daily for 2-8 weeks.

Main Results:

• Excellent treatment results were achieved in 85.2% of dogs (23/27).
• Fair results were observed in 11.1% of dogs (3/27).
• One dog (3.7%) showed no response to the enrofloxacin therapy.

Conclusions:

• Enrofloxacin is an effective antimicrobial treatment for bacterial infections causing German Shepherd Dog Pyoderma (GSP).
• The study supports the use of enrofloxacin for managing GSP in German Shepherd dogs.